Connect with us

Business

Merck Covid-19 Pill Prescribed Frequently in Some Countries Despite Low Efficacy

Doctors in some nations are continuously prescribing a Covid-19 antiviral from Merck & Co., as security concerns about a more effective pill from Pfizer Inc. mixing with different drugs tackle higher significance than elsewhere.

Merck’s drug, which it developed with Ridgeback Biotherapeutics LP, has been administered to sufferers greater than Pfizer’s Paxlovid in Australia, Japan and Italy, regardless of analysis displaying Paxlovid to be significantly better at keeping people out of hospitals.

Related Topics:Antivirals Business Business/Consumer Services clinical consumer services countries Covid Covid19 diagnostic services Efficacy epidemics Frequently general news Health healthcare Healthcare Support Services Healthcare/Life Sciences Infectious Diseases life sciences medical Medical Conditions Medical Research Services Medical/Clinical/Diagnostic Services medications Merck MRK Novel Coronaviruses outbreaks Outbreaks/Epidemics PFE Pfizer Pharmaceuticals pill political Political/General News Prescribed Respiratory Tract Diseases retail Retail/Wholesale Ridgeback Biotherapeutics Scientific Research Services specialized drugs Specialized Drugs/Medications SYND wholesale Wholesalers WSJ-PRO-WSJ.com wsjhealth

How Food Became Putin's New Strategic Weapon

Americans Have Had It With Inflation

Continue Reading

Click to comment

Leave a Reply
Cancel reply

Technology6 months ago

Elon Musk’s affordable internet service Starlink debuts in Japan

Sports5 months ago

Cam Rising gives No. 20 Utah the lift it needs to stun No. 7 USC

Travel5 months ago

Travel agency services market to reach USD 407.7 Bn in 2022

Business6 months ago

Toyota Starts Plant in Junta-Led Myanmar Making 1 to 2 Cars a Day

World10 months ago

U.K. Economy Shrinks for Second Month as Outlook Dims

Entertainment7 months ago

Dancing With the Stars 2022 Cast Revealed

Health8 months ago

Children Hospitalized for COVID-19 Health Issues

Fashion6 months ago

French brand LVMH’s organic revenue grows 19% in Q3